Study S002799

A Phase 2, Multiple Centers, Double-blind, Placebo-Controlled, Randomised Study to Evaluate the Efficacy and Safety of HS-20004 in Type 2 Diabetes Subjects.

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT03848793
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE2
Masking: QUADRUPLE
Status: COMPLETED
Enrollment: 128
Start: 2019-03-06
Primary completion: 2020-06-04
Lead sponsor: Jiangsu HengRui Medicine Co., Ltd.
Conditions: Diabetes Mellitus, Type 2
Interventions: DRUG:HS-20004
Results posted: FALSE
Individual participant data sharing: NO

Registered primary outcomes

HbA1c [16 weeks treatment]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.